{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:12:27Z","timestamp":1778022747696,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T00:00:00Z","timestamp":1234396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00417-009-1050-5","type":"journal-article","created":{"date-parts":[[2009,2,11]],"date-time":"2009-02-11T03:17:13Z","timestamp":1234322233000},"page":"745-754","source":"Crossref","is-referenced-by-count":15,"title":["Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT)"],"prefix":"10.1007","volume":"247","author":[{"given":"Matthias","family":"L\u00fcke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Focke","family":"Ziemssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"V\u00f6lker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Altpeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Beutel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothea","family":"Besch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl Ulrich","family":"Bartz-Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faik","family":"Gelisken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,12]]},"reference":[{"key":"1050_CR1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0161-6420(92)31871-8","volume":"99","author":"R Klein","year":"1992","unstructured":"Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99:933\u2013943","journal-title":"Ophthalmology"},{"issue":"14","key":"1050_CR2","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, ANCHOR Study Group (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355(14):1432\u20131444. doi: 10.1056\/NEJMoa062655","journal-title":"N Engl J Med"},{"issue":"11","key":"1050_CR3","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1517\/14712598.6.11.1237","volume":"6","author":"DJ Pieramici","year":"2006","unstructured":"Pieramici DJ, Avery RL (2006) Ranibizumab: treatment in patients with neovascular age-related macular degeneration. Expert Opin Biol Ther 6(11):1237\u20131245. doi: 10.1517\/14712598.6.11.1237","journal-title":"Expert Opin Biol Ther"},{"issue":"8","key":"1050_CR4","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00417-006-0524-y","volume":"245","author":"F Gelisken","year":"2007","unstructured":"Gelisken F, Voelker M, Schwabe R, Besch D, Aisenbrey S, Szurman P, Grisanti S, Herzau V, Bartz-Schmidt KU (2007) Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). Graefes Arch Clin Exp Ophthalmol 245(8):1085\u20131095. doi: 10.1007\/s00417-006-0524-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"1050_CR5","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00417-007-0558-9","volume":"245","author":"M L\u00fcke","year":"2007","unstructured":"L\u00fcke M, Ziemssen F, Bartz-Schmidt KU, Gelisken F (2007) Quality of life in a prospective, randomised pilot-trial of photodynamic therapy versus full macular translocation in treatment of neovascular age-related macular degeneration\u2014a report of 1 year results. Graefes Arch Clin Exp Ophthalmol 245(12):1831\u20131836. doi: 10.1007\/s00417-007-0558-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"1050_CR6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00417-007-0726-y","volume":"246","author":"F Ziemssen","year":"2008","unstructured":"Ziemssen F, L\u00fcke M, Bartz-Schmidt KU, Gelisken F (2008) Time-dependent effects on contrast sensitivity, near and distance acuity: difference in functional parameters? (Prospective, randomized pilot trial of photodynamic therapy versus full macular translocation). Graefes Arch Clin Exp Ophthalmol 246(5):653\u2013659. doi: 10.1007\/s00417-007-0726-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1050_CR7","first-page":"1","volume":"4","author":"A Colenbrander","year":"1990","unstructured":"Colenbrander A, Fletcher DC (1990) Visual acuity measurements in low vision patients. J Vis Rehabil 4:1\u20139","journal-title":"J Vis Rehabil"},{"key":"1050_CR8","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, National Eye Visual Function Questionnaire Field Test Investigators (2001) Development of the 25-item National eye institute visual function questionnaire. Arch Ophthalmol 119:1050\u20131058","journal-title":"Arch Ophthalmol"},{"key":"1050_CR9","first-page":"2859","volume":"43","author":"JA Stelmack","year":"2002","unstructured":"Stelmack JA, Stelmack TR, Massof RW (2002) Measuring low-vision rehabilitation outcomes with the NEI VFQ-25. Invest Ophthalmol Vis Sci 43:2859\u20132868","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1050_CR10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archopht.121.2.211","volume":"121","author":"TE Clemons","year":"2003","unstructured":"Clemons TE, Chew EY, Bressler SB, McBee W, for the AREDS Research Group (2003) National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS). Arch Ophthalmol 121:211\u2013217","journal-title":"Arch Ophthalmol"},{"key":"1050_CR11","first-page":"227","volume":"116","author":"CM Mangione","year":"1998","unstructured":"Mangione CM, Berry S, Spritzer K (1998) Identifying the content area for the 51-item National Eye Institute Visual Function Questionaire: results from focus groups with visually impaired persons. Arch Ophthalmol 116:227\u2013233","journal-title":"Arch Ophthalmol"},{"key":"1050_CR12","first-page":"178","volume":"7","author":"GH Franke","year":"1998","unstructured":"Franke GH, Esser J, Voigtl\u00e4nder A, M\u00e4hner N (1998) Der National Eye Institute Visual Function Questionnaire (NEI-VFQ) \u2014 Erste Ergebnisse zur psychometrischen \u00dcberpr\u00fcfung eines Verfahrens zur Erfassung der Lebensqualit\u00e4t bei Sehbeeintr\u00e4chtigten. Z Mol Psychol 7:178\u2013184","journal-title":"Z Mol Psychol"},{"key":"1050_CR13","unstructured":"Mangione CM (2000) The NEI VFQ-25 Scoring Algorithm. http:\/\/catalog.nei.nih.gov\/productcart\/pc\/viewPrd.asp?idcategory=50&idproduct=60# )"},{"key":"1050_CR14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","author":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group","year":"1999","unstructured":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of two randomized clinical trials. TAP Report 1. Arch Ophthalmol 117:1329\u20131345","journal-title":"Arch Ophthalmol"},{"key":"1050_CR15","first-page":"198","volume":"119","author":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group","year":"2001","unstructured":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of two randomized clinical trials. TAP Report 2. Arch Ophthalmol 119:198\u2013207","journal-title":"Arch Ophthalmol"},{"key":"1050_CR16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s004170050239","volume":"237","author":"C Eckardt","year":"1999","unstructured":"Eckardt C, Eckardt U, Conrad H-G (1999) Macular rotation with or without counter-rotation of the globe of the patients with agerelated macular degeneration. Graefes Arch Clin Exp Ophthalmol 237:313\u2013325. doi: 10.1007\/s004170050239","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1050_CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archopht.120.4.451","volume":"120","author":"S Aisenbrey","year":"2002","unstructured":"Aisenbrey S, Lafaut BA, Szurman P, Grisanti S, Luke C, Krott R, Thumann G, Fricke J, Neugebauer A, Hilgers RD, Esser P, Walter P, Bartz-Schmidt KU (2002) Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol 120:451\u2013459","journal-title":"Arch Ophthalmol"},{"key":"1050_CR18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/bjo.87.5.615","volume":"87","author":"A Abdel-Meguid","year":"2003","unstructured":"Abdel-Meguid A, Lappas A, Hartmann K, Auer F, Schrage N, Thumann G, Kirchhof B (2003) One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol 87:615\u2013621. doi: 10.1136\/bjo.87.5.615","journal-title":"Br J Ophthalmol"},{"key":"1050_CR19","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.ophtha.2004.03.022","volume":"111","author":"P Mruthyunjaya","year":"2004","unstructured":"Mruthyunjaya P, Stinnett SS, Toth CA (2004) Change in visual function after macular translocation with 360\u00b0 retinectomy for neovascular age-related macular degeneration. Ophthalmology 111:1715\u20131724. doi: 10.1016\/j.ophtha.2004.03.022","journal-title":"Ophthalmology"},{"key":"1050_CR20","doi-asserted-by":"crossref","unstructured":"McClure ME, Hart PM, Jackson AJ, Stevenson MR, Chakravarthy (2000) Macular degeneration: do conventional measurements of impaired visual function equate with visual disability? Br J Ophthalmol 84:244\u2013250. doi: 10.1136\/bjo.84.3.244","DOI":"10.1136\/bjo.84.3.244"},{"key":"1050_CR21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bjo.86.9.1019","volume":"86","author":"L Tejeria","year":"2007","unstructured":"Tejeria L, Harper RA, Artes PH, Dickinson CM (2007) Face recognition in age related macular degeneration: perceived disability, measured disability, and performance with a bioptic device. Br J Ophthalmol 86:1019\u20131026. doi: 10.1136\/bjo.86.9.1019","journal-title":"Br J Ophthalmol"},{"key":"1050_CR22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1167\/iovs.05-0582","volume":"47","author":"I Patel","year":"2006","unstructured":"Patel I, Turano KA, Broman AT, Bandeen-Roche K, Munoz B, West SK (2006) Measures of visual function and percentage of preferred walking speed in older adults. Invest Ophthalmol Vis Sci 47:65\u201371. doi: 10.1167\/iovs.05-0582","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1050_CR23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ageing\/20.3.175","volume":"20","author":"SR Lord","year":"1991","unstructured":"Lord SR, Clark RD, Webster IW (1991) Visual acuity and contrast sensitivity in relation to falls in an elderly population. Age Ageing 20:175\u2013181. doi: 10.1093\/ageing\/20.3.175","journal-title":"Age Ageing"},{"key":"1050_CR24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ageing\/afg110","volume":"32","author":"HKM Lee","year":"2003","unstructured":"Lee HKM, Scudds RJ (2003) Comparison of balance in older people with and without visual impairment. Age Ageing 32:643\u2013649. doi: 10.1093\/ageing\/afg110","journal-title":"Age Ageing"},{"key":"1050_CR25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ophtha.2004.06.035","volume":"112","author":"MT Cahill","year":"2005","unstructured":"Cahill MT, Stinnett SS, Banks AD, Freedman SF, Toth CA (2005) Quality of Life after Macular Translocation with 360\u00b0 Peripheral Retinectomy for Age-Related Macular Degeneration. Ophthalmology 112:144\u2013151. doi: 10.1016\/j.ophtha.2004.06.035","journal-title":"Ophthalmology"},{"issue":"8","key":"1050_CR26","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s00417-005-0218-x","volume":"244","author":"AW Hewitt","year":"2006","unstructured":"Hewitt AW, Jeganathan SV, Kidd JE, Pesudovs K, Verma N (2006) Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life. Graefes Arch Clin Exp Ophthalmol 244(8):972\u2013977. doi: 10.1007\/s00417-005-0218-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1050_CR27","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1136\/bjo.2003.038604","volume":"88","author":"AM Armbrecht","year":"2004","unstructured":"Armbrecht AM, Aspinall PA, Dhillon B (2004) A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration. Br J Ophthalmol 88:1270\u20131273. doi: 10.1136\/bjo.2003.038604","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"1050_CR28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ophtha.2004.06.036","volume":"112","author":"MT Cahill","year":"2005","unstructured":"Cahill MT, Banks AD, Stinnett SS, Toth CA (2005) Vision-Related Quality of Life in Patients with Bilateral Severe Age-related Macular Degeneration. Ophthalmology 112(1):152\u2013158. doi: 10.1016\/j.ophtha.2004.06.036","journal-title":"Ophthalmology"},{"issue":"3","key":"1050_CR29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/01.icu.0000120710.35941.3f","volume":"15","author":"RJ Casten","year":"2004","unstructured":"Casten RJ, Rovner BW, Tasman W (2004) Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol 15(3):181\u2013183. doi: 10.1097\/01.icu.0000120710.35941.3f","journal-title":"Curr Opin Ophthalmol"},{"issue":"10","key":"1050_CR30","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0161-6420(01)00754-0","volume":"108","author":"BL Brody","year":"2001","unstructured":"Brody BL, Gamst AC, Williams RA, Smith AR, Lau PW, Dolnak D, Rapaport MH, Kaplan RM, Brown SI (2001) Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 108(10):1893\u20131900. doi: 10.1016\/S0161-6420(01)00754-0","journal-title":"Ophthalmology"},{"key":"1050_CR31","first-page":"A4545","volume":"48","author":"Y Yang","year":"2007","unstructured":"Yang Y, ANCHOR study group (2007) Two year contrast sensitivity results from the ANCHOR study comparing intravitreal ranibizumab 0.3\u00a0mg and 0.5\u00a0mg with verteporfin photodynamic therapy for predominantly classic CNV lesions secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci 48:A4545","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"1050_CR32","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archopht.125.11.1460","volume":"125","author":"TS Chang","year":"2007","unstructured":"Chang TS, Bressler NM, Fine JT, Dolan CM, Ward J, Klesert TR (2007) MARINA Study Group. Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 125(11):1460\u20131469","journal-title":"Arch Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1050-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-009-1050-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1050-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:40:45Z","timestamp":1559058045000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-009-1050-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1007\/s00417-009-1050-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,12]]}}}